Hybrid nanoliposome as a targeted growth inhibitor for Cervical Carcinoma Cell line

Background: targeted cancer nanotherapy represents a golden goal for nanobiotechnology to overcome the severe side effects of conventional chemotherapy. Hybrid nanoliposomes (HLs) composed of L-α-dimyristoylphosphatidylcholine (DMPC) and Polyoxyethylene (23) dodecyl ether (C12 (EO)23 ) can integrate...

Full description

Bibliographic Details
Main Authors: Noor A. Awad, Nahi Y. Yassen, Amer T. Tawfeeq, Kismat M. Turki
Format: Article
Language:English
Published: College of Medicine University of Baghdad 2016-01-01
Series:مجلة كلية الطب
Subjects:
Online Access:http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/399